although still at an early stage of clinical assessment , preliminary evidence suggests that nimesulide 200 to 400mg daily is significantly more effective than placebo in reducing the pain , fever and inflammatory symptoms of chronic rheumatoid arthritis or osteoarthritis , respiratory tract infections , otorhinolaryngological diseases , soft tissue and oral cavity inflammation , dysmenorrhoea , phlebitis/thrombosis , urogenital disease and postoperative pain states .
C0030193
pain
C0030201
postoperative pain